Table 2.

Univariate and multivariate analyses of factors associated with overall survival and disease-free survival.

Clinicopathological variable		Overall survival			Disease-free survival
		Univariate	Multivariate		Univariate	Multivariate
	Total (n = 142)	P-value	RR (95% CI)	P-value	P-value	RR (95% CI)	P-value
AGE, YEARS
≤42	55
>42	87	0.399	N	N	0.393	N	N
FIGO STAGE
Ia2	8
Ib1	99
Ib2	10
IIa1	16
IIa2	9	0.630	N	N	0.631	N	N
TUMOR SIZE
≤4	114
>4	28	0.262	N	N	0.268	N	N
PATHOLOGIC TYPES
Squamous cell carcinoma	113
Adenocarcinoma	20
Adenosquamous carcinoma	9	0.332	N	N	0.336	N	N
STROMAL INVASION
<1/2	55
≥1/2	87	0.443	N	N	0.437	N	N
LYMPHOVASCULAR SPACE INVASION
Yes	16
No	126	<0.001*	0.905 (0.215–3.811)	0.892	<0.001*	1.179 (0.297–4.686)	0.815
DIFFERENTIATION GRADE
Well	11
Moderate	51
Poor	80	0.414	N	N	0.409	N	N
PELVIC LYMPH NODE METASTASIS
Yes	29
No	113	<0.001*	0.240 (0.069–0836)	0.025*	<0.001*	0.234 (0.069–0.794)	0.020*
VAGINAL INVOLVEMENT
Yes	3
No	139	0.530	N	N	0.529	N	N
PARAMETRIAL INFILTRATION
Yes	2
No	140	0.610	N	N	0.609	N	N
RECURRENCE
Yes	13
No	129	<0.001*	0.009 (0.002–0.043)	<0.001*	<0.001*	0.007 (0.001–0.037)	<0.001*
INTEGRIN α3 EXPRESSION
Low	75
High	67	0.002*	0.173 (0.042–0.721)	0.016*	0.002*	0.184 (0.044–0.760)	0.019*

RR, relative risk; CI, confidence interval; N, not applicable; FIGO, International Federation of Gynecology and Obstetrics.

^*P < 0.05.

Bold values represent p < 0.05.